Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer.
Manabu KojimaKotaro SugimotoMizuko TanakaYuta EndoHitomi KatoTsuyoshi HondaShigenori FurukawaHiroshi NishiyamaTakafumi WatanabeShu SoedaKeiya FujimoriHideki ChibaPublished in: Cancers (2020)
It can be concluded that aberrant CLDN6 expression is useful to predict poor outcome for endometrial cancer and might be a promising therapeutic target.